Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

New antipsychotic drug in phase I at P&U

April 5, 1996

Pherin develops vomeropherins for anxiety

April 5, 1996

Coronary artery diagnostic to enter clinical studies

April 5, 1996

RSR13 enhances oxygen delivery to tissues

April 5, 1996

Pharmalytics develops anticocaine drugs

April 5, 1996

Pierre Fabre reports hypocholesterolemic organosilanes

April 5, 1996

Vitronectin antagonist from Merck & Co. inhibits bone resorption

April 5, 1996

New antitumor proteins from Alfacell

April 5, 1996

New telomerase inhibitor from Geron

April 5, 1996

Protein kinase C modulators in the pipeline at Procyon

April 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...